Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

NCT06339177

Conditions: Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +26 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Improving Exercise Capacity With a Tailored Physical Activity Intervention

NCT05595577

Conditions: Breast Diseases, Breast Neoplasms, Heart; Functional Disturbance, +19 more
Locations: Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Recruiting

Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults

NCT06664229

Conditions: Accidental Falls, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Korea University Seoul, South Korea

View Trial Details

Recruiting

Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

NCT05376111

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: The First Affliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

NCT00768820

Conditions: 22q11 Deletion Syndrome, Abnormalities, Multiple, Aortic Stenosis, Supravalvular, +32 more
Locations: Schneider Children's Mediac Center of Israel Petah Tikva, Israel

View Trial Details

Recruiting

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

NCT06207123

Conditions: Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

University of Rochester Medical Center, Wilmot Cancer Center Rochester, New York, United States

View Trial Details

Recruiting

Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

NCT07479927

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Hospital Universitario La Paz Madrid, Spain

View Trial Details

Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

NCT04065399

Conditions: Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +16 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

University Of California Care Medical Group - Norris Comprehensive Cancer Center And Hospital Los Angeles, California, United States

Stanford Cancer Institute Palo Alto, California, United States

University of Colorado Aurora, Colorado, United States

View all 57 locations

View Trial Details

Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT03590171

Conditions: Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Australian & New Zealand Childhood Hematology & Oncology Group Clayton, Victoria, Australia

St. Anna Kinderkrebsforschung, CCRI Vienna, Austria

Hòpital Universitaire des Enfants Reine Fabiola Brussels, Belgium

University Hospital Motol Prague, Czechia

View all 15 locations

View Trial Details

Recruiting

Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma

NCT07164560

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: 2nd Affiliated Hospital,School of Medicine,Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions